• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于新型抗肝细胞癌分子研发的异种移植斑马鱼模型

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.

作者信息

Tonon Federica, Farra Rossella, Zennaro Cristina, Pozzato Gabriele, Truong Nhung, Parisi Salvatore, Rizzolio Flavio, Grassi Mario, Scaggiante Bruna, Zanconati Fabrizio, Bonazza Deborah, Grassi Gabriele, Dapas Barbara

机构信息

Department of Medical, Surgical and Health Sciences, University of Trieste, Cattinara Hospital, Strada di Fiume, 447, I 34149 Trieste, Italy.

Stem Cell Research and Application Laboratory, VNUHCM, University of Science, Ho Chi Minh City 72711, Vietnam.

出版信息

Pharmaceuticals (Basel). 2021 Aug 16;14(8):803. doi: 10.3390/ph14080803.

DOI:10.3390/ph14080803
PMID:34451900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8400454/
Abstract

Hepatocellular carcinoma (HCC) is the sixth most common type of tumor and the second leading cause of tumor-related death worldwide. Liver cirrhosis is the most important predisposing factor for HCC. Available therapeutic approaches are not very effective, especially for advanced HCC, which is the most common form of the disease at diagnosis. New therapeutic strategies are therefore urgently needed. The use of animal models represents a relevant tool for preclinical screening of new molecules/strategies against HCC. However, several issues, including animal husbandry, limit the use of current models (rodent/pig). One animal model that has attracted the attention of the scientific community in the last 15 years is the zebrafish. This freshwater fish has several attractive features, such as short reproductive time, limited space and cost requirements for husbandry, body transparency and the fact that embryos do not show immune response to transplanted cells. To date, two different types of zebrafish models for HCC have been developed: the transgenic zebrafish and the zebrafish xenograft models. Since transgenic zebrafish models for HCC have been described elsewhere, in this review, we focus on the description of zebrafish xenograft models that have been used in the last five years to test new molecules/strategies against HCC.

摘要

肝细胞癌(HCC)是全球第六大常见肿瘤类型,也是肿瘤相关死亡的第二大主要原因。肝硬化是HCC最重要的诱发因素。现有的治疗方法效果不佳,尤其是对于晚期HCC,而晚期HCC是该疾病在诊断时最常见的形式。因此,迫切需要新的治疗策略。动物模型的使用是针对HCC进行新分子/策略临床前筛选的一种相关工具。然而,包括动物饲养在内的几个问题限制了当前模型(啮齿动物/猪)的使用。在过去15年中引起科学界关注的一种动物模型是斑马鱼。这种淡水鱼具有几个吸引人的特点,如繁殖时间短、饲养所需空间和成本有限、身体透明以及胚胎对移植细胞不表现出免疫反应。迄今为止,已经开发出两种不同类型的用于HCC的斑马鱼模型:转基因斑马鱼模型和斑马鱼异种移植模型。由于转基因斑马鱼HCC模型已在其他地方进行了描述,在本综述中,我们重点描述过去五年中用于测试针对HCC的新分子/策略的斑马鱼异种移植模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/8400454/9ea51994286d/pharmaceuticals-14-00803-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/8400454/1e89e503084c/pharmaceuticals-14-00803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/8400454/9ea51994286d/pharmaceuticals-14-00803-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/8400454/1e89e503084c/pharmaceuticals-14-00803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d1/8400454/9ea51994286d/pharmaceuticals-14-00803-g002.jpg

相似文献

1
Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules.用于新型抗肝细胞癌分子研发的异种移植斑马鱼模型
Pharmaceuticals (Basel). 2021 Aug 16;14(8):803. doi: 10.3390/ph14080803.
2
Transgenic zebrafish for modeling hepatocellular carcinoma.用于肝细胞癌建模的转基因斑马鱼。
MedComm (2020). 2020 Sep 3;1(2):140-156. doi: 10.1002/mco2.29. eCollection 2020 Sep.
3
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing.用于药物测试的斑马鱼快速且经济高效的异种移植肝细胞癌模型。
Int J Pharm. 2016 Dec 30;515(1-2):583-591. doi: 10.1016/j.ijpharm.2016.10.070. Epub 2016 Oct 29.
4
There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma.肝癌的可疑之处:肝细胞癌的斑马鱼模型。
Cell Mol Gastroenterol Hepatol. 2019;8(3):347-363. doi: 10.1016/j.jcmgh.2019.05.002. Epub 2019 May 18.
5
Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index than Sorafenib via Zebrafish Drug Screening Platform.通过斑马鱼药物筛选平台鉴定出治疗指数优于索拉非尼的新型抗肝癌小分子。
Cancers (Basel). 2019 May 28;11(6):739. doi: 10.3390/cancers11060739.
6
Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio.硫代乙酰胺通过在转基因斑马鱼(Danio rerio)中表达丙型肝炎病毒核心蛋白来加速脂肪性肝炎、肝硬化和肝癌的发展。
Toxicology. 2008 Jan 14;243(1-2):11-22. doi: 10.1016/j.tox.2007.09.007. Epub 2007 Sep 14.
7
Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish.分析斑马鱼非酒精性脂肪性肝病相关肝细胞癌早期进展过程中的肝微环境。
J Vis Exp. 2021 Apr 1(170). doi: 10.3791/62457.
8
Zebrafish as a disease model for studying human hepatocellular carcinoma.斑马鱼作为研究人类肝细胞癌的疾病模型。
World J Gastroenterol. 2015 Nov 14;21(42):12042-58. doi: 10.3748/wjg.v21.i42.12042.
9
A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma.新型多激酶抑制剂SKLB-329作为肝细胞癌治疗药物的临床前评价
Int J Cancer. 2014 Dec 15;135(12):2972-83. doi: 10.1002/ijc.28944. Epub 2014 May 12.
10
Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish.肝脏特异性雄激素受体敲除可减轻斑马鱼早期肝脏肿瘤的发生。
Sci Rep. 2019 Jul 23;9(1):10645. doi: 10.1038/s41598-019-46378-3.

引用本文的文献

1
New Progress in Zebrafish Liver Tumor Models: Techniques and Applications in Hepatocellular Carcinoma Research.斑马鱼肝脏肿瘤模型的新进展:技术及其在肝细胞癌研究中的应用
Int J Mol Sci. 2025 Jan 17;26(2):780. doi: 10.3390/ijms26020780.
2
Zebrafish as an Experimental Model for Human Disease.斑马鱼作为人类疾病的实验模型。
Int J Mol Sci. 2023 May 15;24(10):8771. doi: 10.3390/ijms24108771.
3
Zebrafish patient-derived xenografts accurately and quickly reproduce treatment outcomes in non-small cell lung cancer patients.斑马鱼患者来源异种移植模型能够准确、快速地重现非小细胞肺癌患者的治疗结果。

本文引用的文献

1
Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.没食子酸甲酯,一种源于没食子酸的化合物,通过增加肝癌细胞中的 ROS 产生和细胞凋亡来抑制细胞增殖。
PLoS One. 2021 Mar 16;16(3):e0248521. doi: 10.1371/journal.pone.0248521. eCollection 2021.
2
TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation.TAp73β可促进肝癌去分化。
Cancers (Basel). 2021 Feb 13;13(4):783. doi: 10.3390/cancers13040783.
3
Benefits of Zebrafish Xenograft Models in Cancer Research.
Exp Biol Med (Maywood). 2023 Feb;248(4):361-369. doi: 10.1177/15353702221142612. Epub 2022 Dec 19.
斑马鱼异种移植模型在癌症研究中的益处。
Front Cell Dev Biol. 2021 Feb 11;9:616551. doi: 10.3389/fcell.2021.616551. eCollection 2021.
4
Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update.老龄化社会中肝细胞癌全身治疗的最新进展:2020年更新
Liver Cancer. 2020 Dec;9(6):640-662. doi: 10.1159/000511001. Epub 2020 Nov 17.
5
Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer.通过半乳糖化聚天冬酰胺共聚物靶向递送针对肝细胞癌相关基因的 siRNAs。
J Control Release. 2021 Feb 10;330:1132-1151. doi: 10.1016/j.jconrel.2020.11.020. Epub 2020 Nov 17.
6
Theabrownin Induces Apoptosis and Tumor Inhibition of Hepatocellular Carcinoma Huh7 Cells Through ASK1-JNK-c-Jun Pathway.茶褐素通过ASK1-JNK-c-Jun信号通路诱导肝癌Huh7细胞凋亡并抑制肿瘤生长。
Onco Targets Ther. 2020 Sep 9;13:8977-8987. doi: 10.2147/OTT.S254693. eCollection 2020.
7
lncRNA HOTAIR overexpression induced downregulation of c-Met signaling promotes hybrid epithelial/mesenchymal phenotype in hepatocellular carcinoma cells.长链非编码 RNA HOTAIR 过表达诱导 c-Met 信号下调促进肝癌细胞的混合上皮/间充质表型。
Cell Commun Signal. 2020 Jul 11;18(1):110. doi: 10.1186/s12964-020-00602-0.
8
Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.斑马鱼癌症模型——在非哺乳动物脊椎动物中模拟人类癌症的新见解。
Genes (Basel). 2019 Nov 15;10(11):935. doi: 10.3390/genes10110935.
9
A global view of hepatocellular carcinoma: trends, risk, prevention and management.全球视角下的肝细胞癌:趋势、风险、预防与管理。
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22.
10
Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index than Sorafenib via Zebrafish Drug Screening Platform.通过斑马鱼药物筛选平台鉴定出治疗指数优于索拉非尼的新型抗肝癌小分子。
Cancers (Basel). 2019 May 28;11(6):739. doi: 10.3390/cancers11060739.